Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles
- 1 November 2009
- journal article
- Published by Wiley in Histopathology
- Vol. 55 (5) , 594-599
Abstract
To evaluate the relationship between microvessel density assessed by endoglin expression and the molecular subtypes of human invasive breast carcinomas and whether there is evidence to indicate that angiogenesis could be a putative target for therapy in specific subsets of breast cancer. We studied a series of 161 breast carcinomas, but information was available on only 142 tumours. We correlated endoglin expression with distinct breast carcinoma subgroups classified according to immunohistochemical profiling. Additionally, we compared it with other biomarkers for the aggressive basal-like subset and with available histopathological data. Although the basal-like subtype has higher microvessel density, there are no significant differences with the other molecular subtypes of breast cancer. This study found no significant differences in tumour vascularity in different molecular subtypes of breast cancer.Keywords
This publication has 23 references indexed in Scilit:
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomasVirchows Archiv, 2005
- Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2005
- Angiogenesis and Lung Cancer: Prognostic and Therapeutic ImplicationsJournal of Clinical Oncology, 2005
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- The Hallmarks of CancerCell, 2000
- Angiogenesis and metastasisEuropean Journal of Cancer, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996